The Frequency of Epidermal Growth Factor Receptor (EGFR) Mutation in Patients with Lung Adenocarcinoma Referred to a Lung Diseases Hospital; A Cross-Sectional Study from Iran
- سال انتشار: 1401
- محل انتشار: فصلنامه آسیب شناسی ایران، دوره: 17، شماره: 2
- کد COI اختصاصی: JR_IJP-17-2_006
- زبان مقاله: انگلیسی
- تعداد مشاهده: 353
نویسندگان
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Department of Pathology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Department of Pathology, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Tobacco Prevention and Control Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
چکیده
Background & Objective: Various studies showed the use of epidermal growth factor receptors (EGFRs) gene mutations in the therapeutic plan of patients with advanced lung cancer. This study aimed to investigate the frequency and types of EGFR gene mutations among Iranian patients with lung adenocarcinoma referred to a specialized lung diseases hospital from ۲۰۱۴ to ۲۰۱۹.Methods: The data of all patients with lung adenocarcinoma referred to the Molecular Department of Masih Daneshvari Hospital Laboratory (National Research Institute of Tuberculosis and Lung Diseases) from ۲۰۱۴ to ۲۰۱۹ for EGFR mutation tests were collected. Patients' characteristics data and information on the frequency and types of EGFR gene mutations were obtained from the hospital information system (HIS). The collected data were analyzed using SPSS ۲۵.Results: A total of ۵۷۰ individuals (Mean age of ۵۸.۷۴, ۵۱.۶% Male) were included in the study; ۱۱۳ out of ۵۷۰ patients (۱۹.۸%) were diagnosed with gene mutation. In terms of the type of mutation, ۶۵ participants (۵۷%) showed deletion, ۴۸ patients (۴۲.۱%) were diagnosed with replacement, and one (۰.۹%) case demonstrated both. Notably, the mutation rate detected among the female patients was significantly higher than the male ones (P=۰.۰۰۱); in particular, deletion type of mutation was found more among women, although both genders were the same in terms of the replacement frequency. However, the age had no effect on the mutation in this study (P=۰.۰۵).Conclusion: Among Iranian patients with lung adenocarcinoma, ۱۹.۸% harbored EGFR gene mutation. This mutation was found in association with lung cancer and could affect the patient's therapeutic plan.کلیدواژه ها
Adenocarcinoma, EGFR Mutation, Frequency, Iranian population, Lung cancer, Smokingاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.